Prime Capital Investment Advisors, LLC Gilead Sciences, Inc. Transaction History
Prime Capital Investment Advisors, LLC
- $6.63 Billion
- Q2 2024
A detailed history of Prime Capital Investment Advisors, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Prime Capital Investment Advisors, LLC holds 39,739 shares of GILD stock, worth $3.3 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
39,739
Previous 48,972
18.85%
Holding current value
$3.3 Million
Previous $3.59 Million
24.0%
% of portfolio
0.04%
Previous 0.05%
Shares
24 transactions
Others Institutions Holding GILD
# of Institutions
1,879Shares Held
1.02BCall Options Held
12MPut Options Held
8.96M-
Black Rock Inc. New York, NY121MShares$10 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$9.57 Billion0.15% of portfolio
-
Capital World Investors Los Angeles, CA76.2MShares$6.33 Billion0.88% of portfolio
-
Capital Research Global Investors Los Angeles, CA60.4MShares$5.02 Billion0.94% of portfolio
-
State Street Corp Boston, MA59.3MShares$4.93 Billion0.18% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $104B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...